Drugs that contain Midazolam
1. Midazolam In 0.9% Sodium Chloride patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10966990 | INFORLIFE | Midazolam in flexible bags |
Jun, 2038
(14 years from now) | |
Market Authorisation Date: 22 March, 2021
Treatment: NA
Dosage: SOLUTION;INTRAVENOUS
How can I launch a generic of MIDAZOLAM IN 0.9% SODIUM CHLORIDE before it's drug patent expiration?
More Information on Dosage
MIDAZOLAM IN 0.9% SODIUM CHLORIDE family patents
2. Nayzilam patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9687495 | UCB INC | Methods and systems for the delivery of a therapeutic agent |
Jan, 2028
(3 years from now) | |
| US8217033 | UCB INC | Methods and compositions for the delivery of a therapeutic agent |
Jan, 2028
(3 years from now) | |
| US9289432 | UCB INC | Methods and compositions for the delivery of a therapeutic agent |
Jan, 2028
(3 years from now) | |
| US8809322 | UCB INC | Methods and compositions for the delivery of a therapeutic agent |
Jan, 2028
(3 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| Orphan Drug Exclusivity(ODE-243) | May 17, 2026 |
| New Product(NP) | May 21, 2022 |
Market Authorisation Date: 17 May, 2019
Treatment: Acute treatment of intermittent, stereotypic episodes of frequent seizure activity (i.e., seizure clusters, acute repetitive seizures) that are distinct from a patient's usual seizure pattern in patie...
Dosage: SPRAY;NASAL
How can I launch a generic of NAYZILAM before it's drug patent expiration?
More Information on Dosage
NAYZILAM family patents